241 related articles for article (PubMed ID: 20691165)
1. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice.
Tanaka N; Zhang X; Sugiyama E; Kono H; Horiuchi A; Nakajima T; Kanbe H; Tanaka E; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2010 Nov; 80(10):1601-12. PubMed ID: 20691165
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
3. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
4. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice.
Kajikawa S; Harada T; Kawashima A; Imada K; Mizuguchi K
Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):229-38. PubMed ID: 19328666
[TBL] [Abstract][Full Text] [Related]
5. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
[TBL] [Abstract][Full Text] [Related]
7. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.
Nakajima T; Tanaka N; Kanbe H; Hara A; Kamijo Y; Zhang X; Gonzalez FJ; Aoyama T
Mol Pharmacol; 2009 Apr; 75(4):782-92. PubMed ID: 19124612
[TBL] [Abstract][Full Text] [Related]
8. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation.
de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC
J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
10. PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
Hu X; Tanaka N; Guo R; Lu Y; Nakajima T; Gonzalez FJ; Aoyama T
J Nutr Biochem; 2017 Jan; 39():77-85. PubMed ID: 27816763
[TBL] [Abstract][Full Text] [Related]
11. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
Gao M; Bu L; Ma Y; Liu D
PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
13. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
15. Cide-a and Cide-c are induced in the progression of hepatic steatosis and inhibited by eicosapentaenoic acid.
Jinno Y; Nakakuki M; Sato A; Kawano H; Notsu T; Mizuguchi K; Shimano H
Prostaglandins Leukot Essent Fatty Acids; 2010 Aug; 83(2):75-81. PubMed ID: 20542418
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice.
Chan SM; Zeng XY; Sun RQ; Jo E; Zhou X; Wang H; Li S; Xu A; Watt MJ; Ye JM
Biochim Biophys Acta; 2015 Jul; 1852(7):1511-9. PubMed ID: 25906681
[TBL] [Abstract][Full Text] [Related]
17. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
18. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
Chang YY; Su HM; Chen SH; Hsieh WT; Chyuan JH; Chao PM
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973445
[TBL] [Abstract][Full Text] [Related]
19. Dietary Betaine Mitigates Hepatic Steatosis and Inflammation Induced by a High-Fat-Diet by Modulating the Sirt1/Srebp-1/Pparɑ Pathway in Juvenile Black Seabream (
Jin M; Shen Y; Pan T; Zhu T; Li X; Xu F; Betancor MB; Jiao L; Tocher DR; Zhou Q
Front Immunol; 2021; 12():694720. PubMed ID: 34248992
[TBL] [Abstract][Full Text] [Related]
20. Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis.
Seidemann L; Krüger A; Kegel-Hübner V; Seehofer D; Damm G
Molecules; 2021 Feb; 26(4):. PubMed ID: 33671486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
